WILMINGTON, Mass., March 25, 2014 /PRNewswire/
-- Implant Sciences Corporation (OTCQB:IMSC), a high
technology supplier of systems and sensors for homeland security
and defense markets, announced today that its QS-B220 desktop
explosives trace detector (ETD) has received regulatory approval
from the German Federal Ministry of the Interior for aviation
security applications at German airports. The QS-B220 fulfills
specifications set by the German Federal Police. With the German
Federal Ministry of the Interior approval, the QS-B220 may now be
deployed at all non-passenger airport checkpoints for screening of
deliveries, food service, and other airport service functions.
Testing and evaluation was conducted at the German National Test
Center for the Evaluation of Explosives Detection Systems,
established by the German Federal Police, in conjunction with the
Fraunhofer Institute for Chemical Technology (ICT). The realistic
testing environment provided by the Center is essential for
security services and end users such as airport operators to obtain
reliable performance data and ensure a uniform security standard
throughout Europe.
"This testing was performed at the request of an airport in
Germany that plans to use the
QS-B220 to speed up their inspection process at apron checkpoints.
Successful completion of the approval process opens up
opportunities at airports through the region," stated Implant
Sciences' Vice President of Sales and Marketing, Dr. Darryl Jones.
"This product approval, which was performed using the latest
test protocols and obtained through a key testing facility, further
solidifies Implant Sciences' role as the new standard of trace
detection. Our plan is to continue to expand our range of
certifications, which includes the U.S., France, China, and now
Germany. We believe this will
allow us to increase sales volumes and revenues for our Company,"
added Implant Sciences' President and CEO, Glenn D. Bolduc.
On February 4, 2013, the EU
implemented an amendment to Regulation (EU) No 185/2010, in regards
to the screening of passengers and persons other than passengers by
Explosives Trace Detection (ETD) equipment in combination with
Handheld Metal Detection (HHMD) equipment, which stated that
"trials have demonstrated the effectiveness of the combined use of
ETD and HHMD. Moreover, the use of ETD and HHMD may
facilitate the screening process and be experienced to be a less
intrusive means of screening than a hand search, thus constituting
an improvement in the experience of persons screened."
About the QS-B220 Desktop Explosives Trace Detector
The QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly
detect and identify trace amounts of a wide variety of military,
commercial, and homemade explosives. With significantly lower
maintenance requirements than competing systems, the QS-B220 can be
deployed for a much lower total cost of ownership than other
approved products. Featuring a radioactive material-free design,
push-button maintenance and diagnostics, and a patented inCalâ„¢
internal automatic calibration system, the QS-B220 brings new
levels of performance and convenience to desktop trace detection
users with unsurpassed ease of use.
About Implant Sciences
Implant Sciences is the leader in next generation
Explosives Trace Detection (ETD) technology. As of January
2013, the Company is only the third ETD manufacturer, and the first
American-owned company, to currently have product approval from
the US Transportation Security Administration. Implant
Sciences has developed proprietary technologies used in its
commercial explosives and drugs trace detection systems, which ship
to a growing number of locations domestically and
internationally. Implant Sciences' QS-H150 portable
explosives trace detector has received Qualified Anti-Terrorism
Technology Designation and, in addition to receiving TSA
qualification for air cargo screening, the Company's QS-B220 has
also received STAC certification, a Developmental Testing &
Evaluation (DT&E) Designation by the U.S. Department of
Homeland Security under the Support Anti-terrorism by
Fostering Effective Technology Act of 2002 (the SAFETY Act),
and the GSN 2013 Homeland Security Award for "Best Explosives
Detection Solution". For further details on the Company and its
products, please visit the Company's website
at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking
statements," as that term is defined in the Private Securities
Litigation Reform Act of 1995. Such statements are based on
management's current expectations and are subject to risks and
uncertainties that could cause the Company's actual results to
differ materially from the forward-looking statements. Such risks
and uncertainties include, but are not limited to, the risks that
our explosives detection products and technologies (including any
new products we may develop) may not be accepted by the
Transportation Security Administration or by other U.S. or foreign
government and law enforcement agencies or commercial consumers of
security products; economic, political and other risks associated
with international sales and operations could adversely affect our
sales; our business is subject to intense competition and rapid
technological change, and our success will depend on our ability to
develop and introduce new products; and other risks and
uncertainties described in our filings with the Securities and
Exchange Commission, including our most recent Forms 10-K, 10-Q and
8-K. Such statements are based on management's current expectations
and assumptions which could differ materially from the
forward-looking statements.
Contact:
Implant Sciences Corporation
Company Contact:
Glenn Bolduc, CEO
978-752-1700
or
Investor Contact:
Laurel Moody
646-810-0608
SOURCE Implant Sciences Corporation